News - Biotechnology, Licensing


Current filters:


Popular Filters

151 to 175 of 374 results

Transgene out-licenses skin cancer candidate TG1042 to Ascend Pharma


French biotech firm Transgene SA (Euronext Paris: TNG) has granted Ascend Biopharmaceuticals, an emerging…

Ascend PharmaASN-002BiotechnologyLicensingOncologyTG1042Transgene

Pharming and SIPI collaboration includes Ruconest marketing in China


Dutch biotech company Pharming Group (NYSE Euronext: PHARM) and Shanghai Institute of Pharmaceutical…

Asia-PacificBiotechnologyCardio-vascularLicensingPharmaceuticalPharmingResearchRuconestSinopharm Group

Immunocore and Genentech collaborate to develop ImmTACs for multiple cancer targets


Immunocore, an Oxford, UK-based biotechnology company developing novel biological drugs known as ImmTACs…


Immune Design and Medicago link up to develop flu vaccines


Privately-held US biotech firm Immune Design and Medicago (TSX: MDG), a Canadian biopharmaceutical company…

Anti-viralsBiotechnologyImmune DesignLicensingMedicagoVaccines

Seattle Genetics takes up option to co-develop additional ADC with Astellas


Japanese drug major Astellas Pharma (TYO: 4503) says that US biotech firm Seattle Genetics (Nasdaq: SGEN)…

ASG-15MEAstellas PharmaBiotechnologyLicensingOncologyPharmaceuticalSeattle Genetics

MorphoSys and Celgene in deal to advance MOR202 for multiple myeloma


German biotech firm MorphoSys (FSE: MOR) and USA-based Celgene (Nasdaq: CELG), the world's largest independent…

BiotechnologyCelgeneEuropeLicensingMergers & AcquisitionsMOR202MorphoSysOncology

Bayer to spend up to $520 million on antibody drug conjugate deal with Seattle Genetics


US biotech firm Seattle Genetics (Nasdaq: SGEN) says it has entered into a new antibody-drug conjugate…

BayerBiotechnologyLicensingOncologyPharmaceuticalSeattle Genetics

Astellas and Cytokinetics collaborate on new frontier of muscle biology


In a second deal announced this month by US biotech firm, Cytokinetics (Nasdaq: CYTK) has entered into…

Astellas PharmaBiotechnologyCK-2127107CytokineticsLicensingPharmaceuticalResearch

Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis


Sweden-based Athera Biotechnologies, which is 65% owned by Karolinska Development, has entered into an…

Athera BiotechnologiesBiotechnologyBoehringer IngelheimCardio-vascularKarolinska DevelopmentLicensing

Genmab and ADC Thera link for antibody drug conjugate combining HuMax-TAC and PBD warhead


Denmark's Genmab (OMX: GEN) and Switzerland-based ADC Therapeutics have entered an agreement to develop…

ADC TherapeuticsBiotechnologyGenmabHuMax-TACLicensingOncologyResearch

AstraZeneca unit links with NGM Biopharma on diabetes and obesity research


Anglo-Swedish drug major AstraZeneca's (LSE: AZN) US biologics R&D subsidiary MedImmune has entered into…

AstraZenecaBiotechnologyDiabetesLicensingMedImmuneMetabolicsNGM BiopharmaceuticalsPharmaceuticalResearch

Bristol-Myers and Simcere agree to co-develop/commercialize Orencia SC in China


US pharma major Bristol-Myers Squibb (NYSE: BMY) and China-based Simcere Pharmaceutical (NYSE: SCR) have…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyBristol-Myers SquibbLicensingOrenciaPharmaceuticalSimcere Pharmaceutical

Amgen and Cytokinetics expand omecamtiv mecarbil accord


USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech company, has expanded its strategic…

AmgenAsia-PacificBiotechnologyCardio-vascularCytokineticsLicensingomecamtiv mecarbil

BioLineRx collaborates with Chinese firm on hep C drug BL-8030


Israeli drug developer BioLineRx (TASE: BLRX) has signed an out-licensing agreement with Jiangsu Chia-tai…

Anti-viralsAsia-PacificBioLineRxBiotechnologyBL-8030Chia-tai Tianqing PharmaceuticalLicensingPharmaceutical

Life Sciences IPOs have biggest month - May - in 13 years, reports Burrill


A total of eight life sciences companies went public on US exchanges in May, the busiest month for initial…

BiotechnologyFinancialLicensingMergers & AcquisitionsPharmaceutical

CytomX signs up to $635 million oncology deal with Pfizer


US biotech firm CytomX Therapeutics, which is developing a new generation of targeted antibody therapeutics,…

BiotechnologyCytomX TherapeuticsLicensingOncologyPfizerPharmaceuticalResearch

Medigene secures SynCore as global partner for EndoTAG-1


German biotech firm Medigene (MDG: GR) has secured SynCore Biotechnology (part of Taiwan's Sinphar Pharmaceutical…

BiotechnologyEndoTAG-1FinancialLicensingMedigeneSynCore Biotechnology

Merck Serono collaborates with China's BeiGene on second-generation BRAF Inhibitor


Merck Serono, a division of Germany's Merck KGaA (MRK: DE), today (May 31) announced that it has signed…

BeiGeneBeiGene-283BiotechnologyLicensingMerck KGaAMerck SeronoOncologyPharmaceutical

Oncothyreon and Array collaborate on anti-HER2 compound ARRY-380


US biotech firms Oncothyreon (Nasdaq: ONTY) and Array BioPharma (Nasdaq: ARRY) plan to collaborate on…

Array BioPharmaARRY-380BiotechnologyLicensingOncologyOncothyreonPharmaceuticalResearch

RedHill Biopharma views regulatory pathway for RHB-101 in CHF and hypertension


Emerging Israeli biopharma company RedHill Biopharma (TASE: RDHL) says that it recently concluded a positive…

BiotechnologyCardio-vascularCarvedilolLicensingPharmaceuticalRedHill BiopharmaRegulationResearchRHB-101

Stallergenes and DBV Technologies partner on developing novel respiratory allergies treatments


French biotech firms DBV Technologies (Euronext: DBV), creator of Viaskin, a new standard in the treatment…

BiotechnologyDBV TechnologiesLicensingResearchRespiratory and PulmonaryStallergenes

Neovacs moving forward in rheumatoid arthritis, say analysts


French biotech firm Neovacs (Alternext Paris: ALNEV) intends to initiate a Phase IIb trial with its lead…


CMC Biologics and RuiYi link on MAb; Deal for Cynviloq rights in EU


Denmark and USA-based contract manufacturers CMC Biologics has entered into an agreement with China's…

Asia-PacificBiotechnologyCMC BiologicsCynviloqEuropeIGDRASOLLicensingOncologyPharmaceuticalResearchRuiYiSamyang BiopharmaceuticalsSorrento Therapeutics

151 to 175 of 374 results

Back to top